Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Codx Stock Analysis Co Diagnostics Inc. Drops 10.75 To 1.66 Key Support And Catalyst Outlook 20260401 Can Parsons Corporation Psn Stock Increase Dividends Price At 55.38 Down 1.13 20260328 Is The Trade Ttd Stock Showing Strength Price At 20.70 Down 6.80 20260408 Is Madrigal Pharmaceuticals Mdgl Stock Volatile Now Price At 544.02 Down 0.52 20260406 What Are Bullish Arguments For Bristow Group Vtol Stock Price At 48.38 Down 0.09 20260408 The biggest catalyst for DigiBridge DBRG nobody is watching 006 20260508 FGN FG shares rise despite 209 EPS miss defying analyst expectations How Warner WMG adapts when conditions change Buying Pressure 20260510 Which Stocks Move Against Paylocity PCTY Hovering 20260418 The key risks discussed in Cineverse CNVS earnings Q1 2026 Profit Surprises GECC Great Elm Q1 earnings beat estimates by 126 percent as EPS of 36 cents reflects strong portfolio performance Rush RSI Stock Surprise Factor Ticks Higher 20260420 Xencor XNCR Stock Optional Convertible Wavering 20260423 Hubbell HUBB Stock AfterHours Trading Tick Up 20260420 Is Ingram INGM stock showing recovery signs Ingram posts 65 percent EPS beat on strong B2B tech demand The one question every Ambitions AHMA investor should ask Eye on Rally 20260506 CX Cemex crushes Q1 estimates with 725 earnings surprise yet shares fall 3 on cautious outlook IGIC International drops 259 after Q4 2025 EPS posts a narrow 13 miss versus analyst estimates CRGY Crescent posts 534 percent Q1 2026 EPS beat shares rise modestly after earnings announcement Googles Next Big Move Why Wall Street May Be Underestimating Alphabets AI and Cloud Potential Wholesale Inflation Surges 6 Annually in April Marking Sharpest Rise Since 2022 Smith SNN Down 061 How Low Could It Go 20260515 RBI Rate Cut Dilutes Old Policy Framework Nomura Says Immunome IMNM Positioned as Compelling Opportunity in Biotech Sector Arqit ARQQ Stock Today Drops 382 Key Support at 1267 20260517 Surrozen SRZN Drops 576 Key Support at 2674 20260517 Qualcomm Leads Chip Stock SellOff as AI Rally Takes a Breather ColgatePalmolive CL Q1 2026 Earnings Narrow EPS Miss Highlights Steady Execution SpaceX Selects Goldman Sachs to Lead Highly Anticipated IPO UK Unemployment Rate Unexpectedly Rises as Iran War Impact Hits Labour Market Nvidia Explores Superlearners as Potential Step Toward AGI Implications for the AI Landscape Bloom Energy and Nebius Partnership Highlights Clean Energy Role in AI Infrastructure Firm Among Top Aschenbrenner Holdings Top Money Market Account Rates May 23 2026 Highest Yield Reaches 401 APY US Jobless Claims Remain Low Signaling Continued Labor Market Resilience Big Techs Influence on Trumps AI Executive Order Reversal Analysts Express Mixed Views on Tech Stocks ServiceTitan Applied Digital and Elastic MPU Q3 2023 Earnings Narrowing Loss in a Quarter of Transition Perdoceo Education Corporation PRDO Q1 2026 Earnings EPS Surpasses Estimates with 5 Surprise TNGX Q1 2026 Earnings ClinicalStage Biotech Reports Slight EPS Miss Stock Slips on No Revenue Odyssey Marine Exploration Inc OMEX Q1 2016 Earnings Surprise Profit Amid Revenue Void U Q1 2026 Earnings NarrowerThanExpected Loss Drives Shares Higher NOMADAR Corp NOMA Gains 286 as Stock Approaches Key Resistance Kodiak Gas Services KGS Gains 182 as Support Holds Resistance Looms Amylyx Pharmaceuticals AMLX Slips 25 as Biotech Sector Faces Renewed Scrutiny Monte Rosa Therapeutics GLUE Edges Lower Holding Near Key Support Level COCH Envoy Med reports wider than expected Q3 2025 loss shares climb 672 percent on positive investor sentiment What Microbot Medical MBOT does that makes it resilient 429 20260506 How Ferguson Enterprises FERG cash generation compares to earnings Ferguson Enterprises Matches Forecasts Wells Fargo Company WFC Recent Analyst Rating Divergence Price Performance and Jim Cramers Historical Position Disclosure Is Utah UTMD stock near support Utah posts 109 EPS on steady core medical device sales momentum